tradingkey.logo

Bioventus Inc

BVS
View Detailed Chart

6.180USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
409.31MMarket Cap
LossP/E TTM

Bioventus Inc

6.180

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-5.21%

5 Days

-5.94%

1 Month

-11.97%

6 Months

-41.14%

Year to Date

-41.14%

1 Year

-7.07%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts
BUY
Current Rating
14.000
Target Price
126.54%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
8
Average
Company name
Ratings
Analysts
Bioventus Inc
BVS
4
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Strong sell
Sell(11)
Neutral(1)
Buy(0)
Indicators
Sell(5)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.047
Sell
RSI(14)
37.301
Neutral
STOCH(KDJ)(9,3,3)
30.088
Sell
ATR(14)
0.285
Low Volatility
CCI(14)
-179.525
Sell
Williams %R
82.955
Oversold
TRIX(12,20)
-0.213
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
6.462
Sell
MA10
6.449
Sell
MA20
6.643
Sell
MA50
6.635
Sell
MA100
7.377
Sell
MA200
9.225
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.
Ticker SymbolBVS
CompanyBioventus Inc
CEOMr. Robert E. Claypoole
Websitehttps://www.bioventus.com/
KeyAI